CUSIP 747316107 · who reports it, how much, and how much it matters to them
13 of the 720 hedge fund managers we track reported shares of Quaker Chemical Corp (NYSE: KWR) on Form 13F for 30 June 2026. Between them they reported USD 25m. The largest position belongs to Luminus Management, at USD 12m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Luminus Management9 funds on PPLI.com | USD 12m | 8.5% |
| 2 | Voloridge Investment Management6 funds on PPLI.com | USD 3.6m | 0.0% |
| 3 | Millennium Management6 funds on PPLI.com | USD 3.2m | 0.0% |
| 4 | Squarepoint Ops7 funds on PPLI.com | USD 1.8m | 0.0% |
| 5 | Freestone Grove Partners1 fund on PPLI.com | USD 911,000 | 0.0% |
| 6 | Gamco Asset Management1 fund on PPLI.com | USD 747,000 | 0.0% |
| 7 | Citadel Advisors32 funds on PPLI.com | USD 654,000 | 0.0% |
| 8 | Holocene Advisors2 funds on PPLI.com | USD 399,000 | 0.0% |
| 9 | Brevan Howard Capital Management39 funds on PPLI.com | USD 234,000 | 0.0% |
| 10 | CIBC Asset Management69 funds on PPLI.com | USD 230,000 | 0.0% |
| 11 | Capstone Investment Advisors25 funds on PPLI.com | USD 220,000 | 0.0% |
| 12 | Battery Global Advisors16 funds on PPLI.com | USD 190,000 | 0.1% |
| 13 | The Quarry1 fund on PPLI.com | USD 953 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Luminus Management | USD 12m | 8.5% |
| 2 | Battery Global Advisors | USD 190,000 | 0.1% |
| 3 | Voloridge Investment Management | USD 3.6m | 0.0% |
| 4 | Gamco Asset Management | USD 747,000 | 0.0% |
| 5 | Freestone Grove Partners | USD 911,000 | 0.0% |
| 6 | Squarepoint Ops | USD 1.8m | 0.0% |
| 7 | Brevan Howard Capital Management | USD 234,000 | 0.0% |
| 8 | Millennium Management | USD 3.2m | 0.0% |
| 9 | Holocene Advisors | USD 399,000 | 0.0% |
| 10 | CIBC Asset Management | USD 230,000 | 0.0% |
Quaker Chemical Corp trades under the symbol KWR on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 747316107.
13 of the 720 hedge fund managers PPLI.com tracks reported Quaker Chemical Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Luminus Management (USD 12m), Voloridge Investment Management (USD 3.6m), Millennium Management (USD 3.2m), Squarepoint Ops (USD 1.8m) and Freestone Grove Partners (USD 911,000).
13 managers in our coverage reported it, and between them they run 214 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Luminus Management, where the position was 8.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Quaker Chemical Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.